Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

NCT00184769 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Chronic Renal Insufficiency

Interventions

DRUG: somatropin

Sponsor

Novo Nordisk A/S